Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Abstract Highlights from EHA 2022 : A Spotlight on CLL

July 26, 2022 | CLL, Medscape Oncology, haematology, medical education, oncology 

- PMLiVE

Spotlight on CLL

Ahead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Prof John Gribben, UK, on the most important abstracts to look out for in CLL. Here are some of the highlights:

  1. Big interest in combining ibrutinib and venetoclax with two studies reported, both considering eradicating minimal residual disease (MRD) and how important that is:
    • Ph 3 FLAIR – interim data – at the 2-year mark when patients are discontinuing treatment, 89% of those patient’s bone marrow was MRD negative and 97% of patient’s blood was negative. This wasn’t seen with ibrutinib monotherapy, showing the strength of adding venetoclax to the combination.
    • Ph 2 CAPTIVATE with different treatment arms; some fixed duration and some driven by the endpoint. Translational data reported on the dynamics of looking at MRD, what cells are left, and do they differ – are we selecting out resistant variants? All important questions being addressed.
    • Combinations are being submitted for approval with it now being important to understand who the suitable patient is compared to the other available choices.
  2. Six-year follow-up data with venetoclax monotherapy in patients with 17p deletion – ORR approx. 77%, median OS >5yrs which is a great advantage for this patient population compared to the past, and median PFS of 28 months. Although we are moving beyond venetoclax monotherapy, this shows the level of efficacy that is being achieved.
  3. Update on the Ph 2 BRUIN study with pirtobrutinib and the patients with CLL who have had a median of 3 prior lines of therapy, meaning they are already heavily pre-treated with 86% having received a prior BTK inhibitor. Good responses are seen and now waiting to see how durable these responses are in terms of longer follow-up to see the long-term benefit.

You can also watch the full video here

About Medscape:
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. Medscape is the leading online global destination for physicians and healthcare professionals, providing over 5 million members with the latest medical news, expert opinion, and precision education (CME and CPD) to improve clinical practice and advance health outcomes. Medscape’s unrivalled membership reach and therapeutic expertise deliver education across 30+ specialties in 40+ learning formats, using the latest digital and live technology.

This content was provided by Medscape Education

Company Details

Medscape Logo

Medscape Education

Email
Website

 Latest Content from  Medscape Education 

Leading with Heart: Why Vulnerability is a Force Multiplier

In a world that often prizes "macho" decisiveness, Dr. Lobna Salem (CMO at Viatris) and Dr. Amrit Ray (Board Chairman and former Pfizer executive) are advocating for a more human...

Cardiology Education in the Age of AI: Join Medscape at ACC 2026

  As medical knowledge now doubles every 73 days, the challenge for cardiology clinicians has shifted from finding information to mastering precision. At the American College of Cardiology (ACC) 65th...

Medscape Launches “Where Public Health Meets Practice” Learning Center to Translate Public Health Strategies into Patient Care

  The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...

Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden

Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For...

#ShortenTheJourney

For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...

Why We Must Stop Normalizing the “Pregnancy Itch”

In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical...

The Greatest Form of Caring: Medscape’s Commitment to Advancing Cardiovascular Health

A February Focus on the Heart  While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health....

AI, Agility, and Connected Impact at Alliance 2026

Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in...

Why Sleep Health is the Missing Link in Women’s Wellness

While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...